Related Experiment Videos
Henoch-Schönlein purpura after measles immunization
Acta Paediatrica Japonica : Overseas Edition
|August 1, 1989
Abstract:
A three-year-old boy developed Henoch-Schönlein purpura after measles immunization. To our knowledge Henoch-Schönlein purpura in this setting has not been previously reported. This case illustrates that measles vaccine can act as an inducing factor Henoch-Schönlein purpura.
Insights
Measles immunization can trigger Henoch-Schönlein purpura in children. This rare adverse event highlights the vaccine
Area of Science:
- Pediatric immunology
- Vaccine safety research
Background:
- Henoch-Schönlein purpura (HSP) is a common childhood vasculitis.
- The etiology of HSP is often idiopathic but can be triggered by infections or medications.
Observation:
- A three-year-old boy presented with symptoms of Henoch-Schönlein purpura.
- The onset of HSP occurred shortly after receiving the measles vaccine.
Findings:
- This case represents the first reported instance of Henoch-Schönlein purpura following measles immunization.
- The temporal association suggests a potential causal link between the measles vaccine and HSP development.
Implications:
- This finding warrants further investigation into the immunologic mechanisms linking measles vaccination to HSP.
- Healthcare providers should be aware of this potential adverse event when administering measles vaccines.
- Continued surveillance for vaccine-related adverse events is crucial for ensuring public health.